Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds
Cannabis Law Report
JULY 24, 2021
This filing is part of our continued efforts to grow our robust IP portfolio as we consistently file for new patents that offer high potential to expand psychedelics for medical use.”. The post Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds appeared first on CannabisFN.
Let's personalize your content